There are still lots of open positions. Let's find the one that's right for you.
The Roche/Genentech Clinical Development organization is structured by therapeutic area and is responsible for developing and executing the late stage development (Phase 2-3) clinical strategies and plans to deliver medically differentiated therapies that provide meaningful improvement to patients. The Lead Clinical Scientist is responsible for the clinical science aspects relative to the study team, Study Leadership Team (SLT) or project team and may lead a clinical study or other project as part of these teams in order to support effective and efficient execution of the Clinical Development Plan (CDP) for the molecule/indication. This includes contributing to the clinical science aspects of the CDP strategy and clinical documentation, representing the CDP on appropriate sub-teams and forums, leading training of study site personnel, acting as a primary point-of-contact for questions and enquiries to the CDP at a study level, conducting ongoing medical/safety data reviews, and providing clinical science inputs into study reporting. Lead Clinical Scientists will have interactions with external stakeholders, e.g. investigators, Therapy Area Experts (TAEs) and vendors. Alongside CSL, they may participate in external interactions with Health Authorities (HAs). Lead Clinical Scientists perform their responsibilities independently. You are able to contribute and develop outlines for internal/external clinical presentations and communications (e.g. investigator meetings, study site interactions, patient information, newsletters); you have the ability to present at internal meetings (e.g. Study Leadership Team, Global Development Team) and external meetings (e.g. investigator meetings, advisory boards), abstracts, posters and content for scientific meetings; in addition, you are able to contribute to manuscripts for submission to peer-reviewed journals.